Hepatitis B
Hepatitis B is a viral infectious disease caused by Hepatitis B virus (HBV), a hepatotropic DNA virus that primarily infects the liver.
Hepatitis B is a viral infectious disease caused by Hepatitis B virus (HBV), a hepatotropic DNA virus that primarily infects the liver. Clinically, hepatitis B may present as acute infection or progress to chronic infection, which can lead to cirrhosis, liver failure, and hepatocellular carcinoma. Because chronic HBV infection can persist for years with limited symptoms, it remains a major global public health concern and an important target for vaccination, screening, and antiviral treatment.
Biologically, HBV is notable for its ability to evade host immunity and establish long-term persistence. Recent research contexts highlight HBV’s interactions with immune cells, including macrophage polarization and inhibitory receptor pathways such as CD33-mediated immunosuppression. HBV is also relevant beyond the liver, with reported associations with extrahepatic disease such as membranoproliferative glomerulonephritis, and with clinical decision-making in oncology, where hepatitis B positivity can affect chemotherapy and immunotherapy planning.
Where the papers sit
9 papers from the last 6 months study Hepatitis B directly · updated from PubMed 10 Nov 2026
Study type 1 clinical trial · 6 human data · 2 unclassified
Themes one subject
Those 9 are all about one subject.
-
Hepatitis B Prevention and Care
Vaccination, screening, and clinical management remain the shared focus, spanning adult coverage, migrant catch-up policies, and care for people with HIV. Evidence addresses vaccine schedules, immunogenicity in preterm infants and hemodialysis patients, and vaccination knowledge and guideline adherence. Decision analysis and survey-accuracy studies support better program planning, while deep learning targets autoimmune hepatitis diagnosis. The set is broad and largely descriptive, with no single intervention or outcome dominating.
Papers
The 9 papers from the last 6 months that study Hepatitis B directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Hepatitis B Prevention and Care (9)
- Adherence to European AIDS clinical society hepatitis B management guidelines in people with HIV: real-world evidence from Spain and Germany. AIDS (London, England) · 8 Oct 2026 PMID 42847908
- Prioritizing the introduction of new vaccine in Tanzania (2026-2030): a multi-criteria decision analysis by the Tanzania immunization technical advisory group. Vaccine · 31 Jul 2026 PMID 42537288
- Immunogenicity and safety of a 2 + 1 schedule of the DTaP-IPV-HB-Hib hexavalent combination vaccine in preterm infants in Spain. Human vaccines & immunotherapeutics · 26 Jun 2026 PMID 42359964
- Assessment of knowledge, attitudes, and behaviors regarding vaccinations among LGBTQIA+ community in Italy. Human vaccines & immunotherapeutics · 25 Jun 2026 PMID 42348835
- High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images. Virchows Archiv : an international journal of pathology · 16 Jun 2026 PMID 42301307
- Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients. Vaccine · 30 May 2026 PMID 42217446
- Global Cancer Prevention: Current Approaches and Future Directions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 26 May 2026 PMID 42190157
- Catch-up and life-course vaccination policies for adult and adolescent migrants in low-and-middle income countries: A policy analysis. Vaccine · 22 May 2026 PMID 42172819
- Accuracy of Surveys for Estimating Coverage for Hepatitis A and B Vaccinations in Adults. Preventing chronic disease · 22 May 2026 PMID 42170988
By study type
Clinical trials (1)
- Immunogenicity and safety of a 2 + 1 schedule of the DTaP-IPV-HB-Hib hexavalent combination vaccine in preterm infants in Spain. Human vaccines & immunotherapeutics · 26 Jun 2026 PMID 42359964
Human data, design not indexed (6)
- Prioritizing the introduction of new vaccine in Tanzania (2026-2030): a multi-criteria decision analysis by the Tanzania immunization technical advisory group. Vaccine · 31 Jul 2026 PMID 42537288
- Assessment of knowledge, attitudes, and behaviors regarding vaccinations among LGBTQIA+ community in Italy. Human vaccines & immunotherapeutics · 25 Jun 2026 PMID 42348835
- Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients. Vaccine · 30 May 2026 PMID 42217446
- Global Cancer Prevention: Current Approaches and Future Directions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 26 May 2026 PMID 42190157
- Catch-up and life-course vaccination policies for adult and adolescent migrants in low-and-middle income countries: A policy analysis. Vaccine · 22 May 2026 PMID 42172819
- Accuracy of Surveys for Estimating Coverage for Hepatitis A and B Vaccinations in Adults. Preventing chronic disease · 22 May 2026 PMID 42170988
Unclassified: not yet indexed with MeSH (2)
- Adherence to European AIDS clinical society hepatitis B management guidelines in people with HIV: real-world evidence from Spain and Germany. AIDS (London, England) · 8 Oct 2026 PMID 42847908
- High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images. Virchows Archiv : an international journal of pathology · 16 Jun 2026 PMID 42301307
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-07-01. Last written: 2026-08-27 by GPT. Drafted by language models from published abstracts; not medical advice.